ROCHESTER, N.Y., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), will present at the Rodman & Renshaw Annual Global Investment Conference at 2:25 PM EDT on Monday, September 9, 2013 in New York City.
L. Michael Hone, Chief Executive Officer of Caliber I.D., will describe the Company's platform of VivaScope® confocal microscopes. The FDA-cleared VivaScope® cellular imaging devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy. He will also discuss the Company's strategy, markets and growth plans as they relate to cost efficiency in the scope of medical and dermatological care. In addition, the Company will provide live demonstrations of VivaScope® devices during the conference.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.
CONTACT: Richard Pulsifer Chief Financial Officer (617) 348-9821 Investor Relations: Dian Griesel Inc. Cheryl Schneider (212) 825-3210 email@example.com Public Relations: Dian Griesel Inc. Susan Forman or Laura Radocaj (212) 825-3210 firstname.lastname@example.org email@example.comSource:Caliber Imaging & Diagnostics, Inc.